Inconsistency in Risperidone Long-Acting Injection Steady-State Plasma Levels When Switching From Deltoid to Gluteal Administration

被引：9
|
作者：
Elliott, Ellie S. R. [1 ]
Purvis, Tara L.
Nelson, Leigh Anne
Sommi, Roger W.
机构：
[1] Ctr Behav Med, Kansas City, MO 64108 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2010年 / 50卷 / 06期
关键词：
Risperidone long-acting injection; pharmacokinetics; deltoid injection; gluteal injection;
D O I：
10.1177/0091270009350622
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：721 / 724
页数：4
相关论文
共 50 条
  • [21] Proposing the Use of Partial AUC as an Adjunctive Measure in Establishing Bioequivalence Between Deltoid and Gluteal Administration of Long-Acting Injectable Antipsychotics
    Lik Hang N. Lee
    Charles Choi
    Pavel Gershkovich
    Alasdair M. Barr
    William G. Honer
    Ric M. Procyshyn
    European Journal of Drug Metabolism and Pharmacokinetics, 2016, 41 : 659 - 664
  • [22] Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
    Hori, Hikaru
    Katsuki, Asuka
    Atake, Kiyokazu
    Yoshimura, Reiji
    FRONTIERS IN PSYCHIATRY, 2018, 9
  • [23] The influence of switching from haloperidol decanoate depot to risperidone long-acting injection on the clinical symptoms and cognitive function in schizophrenia
    Suzuki, Hidenobu
    Gen, Keishi
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2012, 27 (05) : 470 - 475
  • [24] Prolactin levels and side effects of long-acting risperidone injection and oral treatments in psychotic disorders
    Szerman, N.
    Basurte-Villamor, I.
    Montes, J. M.
    Hernandez-Herrero, C.
    Sopelana, P.
    Fernandez-Navarro, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S443 - S443
  • [25] Risperidone Long-acting Injection vs. Oral Risperidone: A Secondary Analysis of Relapse and Rehospitalization Controlling for Switching in a Pragmatic Trial
    Schooler, Nina R.
    Gopinath, Srinath
    Weedon, Jeremy
    Buckley, Peter F.
    Goff, Donald C.
    Kopelowicz, Alexander
    Lauriello, John
    Manshreck, Theo
    Mendelowitz, Alan J.
    Miller, Del D.
    Wilson, Daniel R.
    Kane, John M.
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S354 - S355
  • [26] STEADY-STATE EVALUATION OF THEOPHYLLINE (THEOVENT) LONG-ACTING CAPSULES IN ASTHMATIC-PATIENTS
    GURAL, R
    DIGIORE, C
    STRAUSS, M
    VEALS, J
    KORDUBA, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) : 250 - 250
  • [27] Impact of CYP2D6 Genotype on Steady-State Serum Concentrations of Risperidone and 9-Hydroxyrisperidone in Patients Using Long-Acting Injectable Risperidone
    Hendset, Magnhild
    Molden, Espen
    Refsum, Helge
    Hermann, Monica
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (06) : 537 - 541
  • [28] A Case of Tardive Dyskinesia that Regressed After Switching From Risperidone Long-Acting Injectable to Paliperidone 1-Monthly Long-Acting Injectable
    Gokcay, Hasan
    Takim, Ugur
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (06)
  • [29] Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable
    Rosa, Fernanda
    Schreiner, Andreas
    Thomas, Pierre
    Sherif, Tarek
    CLINICAL DRUG INVESTIGATION, 2012, 32 (04) : 267 - 279
  • [30] Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable
    Fernanda Rosa
    Andreas Schreiner
    Pierre Thomas
    Tarek Sherif
    Clinical Drug Investigation, 2012, 32 : 267 - 279
12345